IMDb.com, Inc. takes no responsibility for the content or accuracy of the above news articles, Tweets, or blog posts. This content is published for the entertainment of our users only. The news ...

February 27 - Investors' and economists' concerns that artificial intelligence will upend established industries are deepening, as Goldman Sachs warned in February that accelerating AI adoption could ...

Companies like HP and IBM have signaled they're replacing jobs with AI. HP plans to cut up to 6,000 jobs by 2028, citing AI-driven productivity measures. Klarna's workforce has halved in the last four ...

Novo Nordisk NOVO.B5.96%increase; green up pointing triangle plans to slash U.S. list prices for its popular weight-loss and diabetes drugs Wegovy and Ozempic by up to half starting next year. Under ...

Amid efforts on several fronts to improve the affordability of its GLP-1 medications for diabetes and obesity, Novo Nordisk is taking a new approach by aiming straight for semaglutide’s list price.

Novo Nordisk on Tuesday said it plans to slash the monthly list prices of its popular obesity and diabetes drugs in the U.S. by up to 50% starting in 2027. The move aims to make the treatments more ...

Eli Lilly (LLY) shares turned lower in the premarket on Tuesday after its rival Novo Nordisk (NVO) announced plans to cut the list prices of its GLP-1 medications, Wegovy, Ozempic, and Rybelsus, in ...

Citi Research has trimmed its year-end target for India's Nifty 50, citing mounting risks to growth and corporate earnings and as surging oil and supply shocks from the escalating Middle East war ...

Novo Nordisk announced that it will significantly reduce the U.S. list prices of its widely used weight-loss drugs Wegovy, Ozempic and Rybelsus, starting Jan. 1, 2027. The company said all doses will ...

The Los Angeles Chargers stand as one of the NFL teams with the most obvious major cut candidates around the league this offseason. Jim Harbaugh and Chargers general manager Joe Hortiz worked the ...